Timothy M. Rawson

6.2k citations

92 papers · 3.7k indexed · 1 hit paper · h-index 26

Impact in

Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance
Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria

Papers in

Applied Microbiology and Biotechnology 39
- Antibiotic Use and Resistance 39
Molecular Medicine 15
- Antibiotic Resistance in Bacteria 15

Co-authors: Alison Holmes Luke Moore Mark Gilchrist Giovanni Satta Nina Zhu Pantelis Georgiou Raheelah Ahmad Keira Skolimowska
Journals: Journal of Antimicrobial Chemotherapy (8 papers)International Journal of Infectious Diseases (6 papers)BMC Infectious Diseases (5 papers)Clinical Microbiology and Infection (5 papers)Clinical Infectious Diseases (4 papers)
Partner nations: United Kingdom Thailand United States

In The Last Decade

Timothy M. Rawson

87 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing 2020 · 1.1k citations

Peers

Countries citing papers authored by Timothy M. Rawson

Since Specialization

Citations

This map shows the geographic impact of Timothy M. Rawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy M. Rawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy M. Rawson more than expected).

Fields of papers citing papers by Timothy M. Rawson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy M. Rawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy M. Rawson. The network helps show where Timothy M. Rawson may publish in the future.

Co-authors

The 25 scholars most cited alongside Timothy M. Rawson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy M. Rawson Line = papers co-authored together Timothy M. Rawson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Artificial intelligence and infectious disease diagnostics: state of the art and future perspectives The Lancet Infectious Diseases ·浩治吉田, Timothy M. Rawson, Ronald Galiwango, Chengyi Cai, Damien Ming, 옥은지, Cecilia Ferreyra, Eric O. Aboagye, N Claire Gordon, Carolina García‐Vidal, Jesús Rodríguez-Manzano, Alison Holmes	2025	4
2	Utilising routinely collected clinical data through time series deep learning to improve identification of bacterial bloodstream infections: a retrospective cohort study The Lancet Digital Health ·Damien Ming, lml Liu, Timothy M. Rawson, Pantelis Georgiou, Frances Davies, Alison Holmes, Bernard Hernandez	2025	1
3	Machine learning to predict antimicrobial resistance: future applications in clinical practice? Infectious Diseases Now ·Yousra Kherabi, Michaël Thy, Donia Bouzid, David Antcliffe, Timothy M. Rawson, Nathan Peiffer‐Smadja	2024	11
4	Towards pharmacokinetic boosting of phenoxymethylpenicillin (penicillin-V) using probenecid for the treatment of bacterial infections Scientific Reports ·Richard Wilson, H. Fauser, 通治和田, Damien Ming, Fida Noor, J. Urban, Mark Gilchrist, Anne‐Grete Märtson, William Hope, Alison Holmes, Timothy M. Rawson	2024	0
5	Antimicrobial resistance–attributable mortality: a patient-level analysis JAC-Antimicrobial Resistance ·Xuebei Wan, Timothy M. Rawson, Hamish Houston, Louis Grandjean, Gabriele Pollara	2024	1
6	Triple quadrupole LC/MS method for the simultaneous quantitative measurement of cefiderocol and meropenem in serum Analytical Methods ·H. Fauser, lml Liu, Richard Wilson, Timothy M. Rawson, Efraldo Yudistra, Rishi Dhillon, J. Duckers, Anthony E. G. Cass, Alison Holmes	2023	4
7	A NOVEL METHOD FOR IN - VITRO BETA-LACTAMASE QUANTIFICATION: PROOF-OF-CONCEPT International Journal of Infectious Diseases ·James F. Lawrence, Timothy M. Rawson, Sally A. N. Gowers, Dermot O’Hare, Alison Holmes	2023	1
8	Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia Journal of Antimicrobial Chemotherapy ·lml Liu, A. Nalugooti, Timothy M. Rawson, Alison Holmes, Osman Özşahin	2023	1
9	Antiviral metabolite 3′-deoxy-3′,4′-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19 Med ·Ravi Mehta, Elena Chekmeneva, Heather Jackson, Caroline Sands, F C Bailey, M. Natsume, Ho Kwong Li, 通治和田, Timothy M. Rawson, Robert Hammond, TRIDIP SUHRUD, Alanah Rafferty, Graham Cooke, Mahdad Noursadeghi, Myrsini Kaforou, Matthew R. Lewis, Zoltán Takáts, Shiranee Sriskandan	2022	10
10	A practical laboratory method to determine ceftazidime-avibactam-aztreonam synergy in patients with New Delhi metallo-beta-lactamase (NDM)–producing Enterobacterales infection Journal of Global Antimicrobial Resistance ·Timothy M. Rawson, 何尚琴, Ashutosh Prasad Maurya, Céline Perrudin, Mark Gilchrist, Mehmet Deniz Kozanoglu, Luke Moore, Hugo Donaldson, Frances Davies	2022	17
11	A Surveillance Framework for Healthcare Associated Infections and Antimicrobial Resistance in Acute Care in the Context of COVID-19: A Rapid Literature Review and Expert Consensus SSRN Electronic Journal ·Nina Zhu, Timothy M. Rawson, Raheelah Ahmad, James Price, Mark Gilchrist, Sanjeev K. Singh, Sara Tomczyk, Gabriel Birgand, Visanu Thamlikitkul, 西田幸二, R. B. Vishnurahav, Michael G. Whitfield, Paul Aylin, Alison Holmes	2021	3
12	Informing antimicrobial management in the context of COVID-19: understanding the longitudinal dynamics of C-reactive protein and procalcitonin BMC Infectious Diseases ·Damien Ming, Kent Su, Bernard Hernandez, Andrea Y. Weiße, Robert L. Peach, Mauricio Barahona, Timothy M. Rawson, Alison Holmes	2021	14
13	Optimizing antimicrobial use: challenges, advances and opportunities Nature Reviews Microbiology ·Timothy M. Rawson, Richard Wilson, Danny O’Hare, Pau Herrero, Andrew Kambugu, Mohammed Lamorde, Matthew J. Ellington, Pantelis Georgiou, Anthony E. G. Cass, William Hope, Alison Holmes	2021	84
14	Corrigendum to ‘machine learning for clinical decision support in infectious diseases: a narrative review of current applications’ clinical microbiology and infection (2020) 584–595 Clinical Microbiology and Infection ·Nathan Peiffer‐Smadja, Timothy M. Rawson, Raheelah Ahmad, Albert Buchard, Pantelis Georgiou, F.-X. Lescure, Gabriel Birgand, Alison Holmes	2020	10
15	Forecasting Implementation, Adoption, and Evaluation Challenges for an Electronic Game–Based Antimicrobial Stewardship Intervention: Co-Design Workshop With Multidisciplinary Stakeholders Journal of Medical Internet Research ·Enrique Castro‐Sánchez, Jim Workman, Timothy M. Rawson, 刘立文, Alison Holmes	2019	11
16	Towards a minimally invasive device for beta-lactam monitoring in humans Electrochemistry Communications ·Timothy M. Rawson, Sanjiv Sharma, Pantelis Georgiou, Alison Holmes, Anthony E. G. Cass, Danny O’Hare	2017	39
17	Patient engagement with infection management in secondary care: a qualitative investigation of current experiences BMJ Open ·Timothy M. Rawson, Luke Moore, Bernard Hernandez, Enrique Castro‐Sánchez, Esmita Charani, Pantelis Georgiou, Raheelah Ahmad, Alison Holmes	2016	19
18	Mapping the decision pathways of acute infection management in secondary care among UK medical physicians: a qualitative study BMC Medicine ·Timothy M. Rawson, Esmita Charani, Luke Moore, Bernard Hernandez, Enrique Castro‐Sánchez, Pau Herrero, Pantelis Georgiou, Alison Holmes	2016	43
19	Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study Respiratory Medicine ·Timothy M. Rawson, Aula Abbara, Katharina Kranzer, Andrew I. Ritchie, James Milburn, Tim Brown, David Adeboyeku, K.E. Guerman, Robert N. Davidson, Matthew Berry, Onn Min Kon, Laurence John	2016	13
20	Antimicrobial stewardship: are we failing in cross-specialty clinical engagement? Journal of Antimicrobial Chemotherapy ·Timothy M. Rawson, Luke Moore, Mark Gilchrist, Alison Holmes	2015	13

About Timothy M. Rawson

Timothy M. Rawson is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Health Informatics, Clinical Biochemistry and Pharmacology, having authored 92 papers that have together received 3.7k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (39 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers), Bacterial Identification and Susceptibility Testing (17 papers), Antibiotic Resistance in Bacteria (15 papers), Patient Satisfaction in Healthcare (9 papers), Pneumonia and Respiratory Infections (7 papers), Sepsis Diagnosis and Treatment (7 papers) and COVID-19 diagnosis using AI (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.6k citations), Molecular Medicine (455 citations), Health Informatics (122 citations), Critical Care and Intensive Care Medicine (328 citations) and Infectious Diseases (1.1k citations). Timothy M. Rawson has collaborated with scholars based in United Kingdom, Thailand and United States. Frequent co-authors include Alison Holmes, Luke Moore, Mark Gilchrist, Giovanni Satta, Nina Zhu, Pantelis Georgiou, Raheelah Ahmad, Keira Skolimowska, Graham Cooke and Esmita Charani. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, International Journal of Infectious Diseases, BMC Infectious Diseases, Clinical Microbiology and Infection and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact